<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01001429</url>
  </required_header>
  <id_info>
    <org_study_id>0120090202</org_study_id>
    <nct_id>NCT01001429</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Propofol in Vitreoretinal Surgery</brief_title>
  <official_title>Comparison of Dexmedetomidine vs. Propofol in Vitreoretinal Surgery Under Sub-Tenon's Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators would like to determine if using Dexmedetomidine alone or in a reduced dose
      can prevent or reduce the incidence of adverse effects, while providing adequate sedation,
      and respiratory stability as compared to propofol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Alpha2 adrenergic receptor agonist have been used increasingly as a new armamentarium to
      provide sedative/hypnotic, analgesic, anxiolytic and sympatholytic effects in the
      perioperative settings. Dexmedetomidine, a selective and specific alpha2- adrenoceptor
      agonist has unique properties that makes it an almost ideal sedative drug for monitored
      anesthesia care in procedures under local or regional block. Unlike other drugs use for
      sedation, dexmedetomidine induces sedation that is similar to natural sleep (readily
      arousable) without causing respiratory depression. It attenuates the stress-induced
      sympathoadrenal response seen with laryngoscopy and intubation. It has anesthetic and opioid
      sparing effects, hence it may be a useful adjunct to general anesthesia and monitored
      anesthesia care in patients susceptible to narcotic induced respiratory depression. Another
      unique property of dexmedetomidine is that its sedative effect is reversible with
      Atipamezole. A previous study wherein dexmedetomidine has been used in procedures under local
      and regional block had shown that it provides effective sedation and better operating
      condition without significant respiratory depression. As a supplement to general anesthesia,
      it has been shown to provide stable hemodynamics. However, it is associated with some adverse
      events such as hypertension, hypotension and bradycardia, these commonly occur during bolus
      administration of the recommended dose of 1ug/kg. Post-operatively it can cause nausea and
      vomiting. Vitreoretinal surgery requires either an injection of local anesthetic within the
      muscle cone (retrobulbar block),or into the periorbital space (peribulbar block). This can be
      done individually or in combination. This surgery can also be done under a safer technique of
      retrobulbar block that is given using a sub-tenon's approach through a snip peritomy; a blunt
      cannula can be used with this technique mitigating the complications of retrobulbar
      hemorrhage or inadvertent injection into the optic nerve sheath or perforation of the globe
      using a sharp needle. The anesthetic goal is to provide an immobile and uncongested operative
      field. Hemodynamic stability of the patient is also important since some patients that
      require this procedure are elderly with co-morbid conditions such as hypertension, diabetes
      mellitus and Coronary Artery Disease (CAD). In our study we would like to investigate if
      Dexmedetomidine alone and in a reduced dose can prevent or reduce the incidence of adverse
      effects, provide hemodynamic and respiratory stability, provide adequate sedation with
      patient and surgeon satisfaction and compare it with Propofol.

      Objectives:

      Primary:

        1. Adequate sedation

        2. Hemodynamic and respiratory stability intraoperatively

      Secondary:

        1. surgeon satisfaction

        2. Time to achieved &quot; street fitness &quot; status

        3. subject satisfaction

        4. Hemodynamic stability in PACU
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adequate Sedation Via Bispectral Index Score (BIS)and University of Michigan Sedation Scale (UMSS)</measure>
    <time_frame>Intraoperative up to 120 min</time_frame>
    <description>Bispectral Index Score measurement uses processed electroencephalogram signals to measure sedation depth of a scale from 0-100 (0=coma; 40-60=general anesthesia;60-90 sedated;100=awake) University of Michigan Sedation Scale (1-4) is an observational scale that quantifies sedation.1=normal response to verbal stimuli, 2=conscious sedation, responsive to tactile stimuli, 3= deeply sedated responsive to repeated or painful stimuli, 4=general anesthesia: not arousable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative Hemodynamic Stability</measure>
    <time_frame>Intraoperative up to 120 min</time_frame>
    <description>systolic and diastolic blood pressure was recorded at 5 minute intervals up to 120 min and were averaged per study arm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative Respiratory Stability</measure>
    <time_frame>Intraoperative up to 120 min</time_frame>
    <description>respiratory rate data were recorded at 5 minutes intervals throughout the surgical procedure up to 120 mins for both groups and averaged per study arm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraoperative Heart Rate Stability</measure>
    <time_frame>Intraoperative up to 120 min</time_frame>
    <description>Heart rate recorded at 5 minute intervals during surgery up to 120 min and averaged per study arm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Achieve &quot;Street Fitness&quot;</measure>
    <time_frame>for 2 hours post-operatively in Post Anesthesia Care unit</time_frame>
    <description>Subjects will be kept in the Post Anesthesia Care Unit (PACU) for a period of 2 hours. However it will be documented as to when, in the opinion of the PACU staff, the subject has met the criteria for discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon Satisfaction for Adequate Sedation</measure>
    <time_frame>at 10 minutes into the procedure</time_frame>
    <description>1=very poor, 2=poor,3=fair, 4=good, 5=excellent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon Satisfaction for Adequate Sedation at Completion of Procedure</measure>
    <time_frame>immediately following the completion of the procedure up to one hour</time_frame>
    <description>surgeon satisfaction graded on numerical scale 1=very poor. 2=poor, 3=fair 4=good, 5=excellent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>measured prior to discharge up to 2 hours</time_frame>
    <description>1=very poor, 2=poor, 3=fair, 4=very good, 5=excellent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Operative Hemodynamic Stability</measure>
    <time_frame>2 hours in PACU</time_frame>
    <description>blood pressure documented at 30 minute intervals in PACU up to 120 min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic Stability Post Operatively in PACU</measure>
    <time_frame>PACU to 2 hours post op</time_frame>
    <description>heart rate recorded at 30 min intervals in PACU up to 120 min</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Retinal Detachment</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>propofol 1mg/kg as a bolus intravenously followed by an infusion of 25-100 ug/kg/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will receive a bolus of0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine infusion</intervention_name>
    <description>bolus of 0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug</description>
    <arm_group_label>dexmedetomidine infusion</arm_group_label>
    <other_name>Precedex infusion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>propofol 1mg/kg intravenously as a bolus followed by 25-100ug/kg/min</description>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists rating of I-III

          -  good renal and liver function

        Exclusion Criteria:

          -  renal and hepatic insufficiency

          -  uncontrolled diabetes

          -  uncontrolled hypertension

          -  severe cardiac disease Class III or IV

          -  heart blocks

          -  chronic use of sedatives, narcotics, alcohol or illicit drugs

          -  allergy to either propofol or dexmedetomidine

          -  pregnancy or inability to tolerate technique of the study drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anuradha Patel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers /NJMS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UMDNJ-University Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2009</study_first_submitted>
  <study_first_submitted_qc>October 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2009</study_first_posted>
  <results_first_submitted>February 11, 2016</results_first_submitted>
  <results_first_submitted_qc>July 18, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 21, 2017</results_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sedation for vitreoretinal surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Detachment</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited the morning of surgery in the Same Day Surgery Suite</recruitment_details>
      <pre_assignment_details>One subject withdrew consent prior to group assignment. One subject surgery was cancelled</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Propofol</title>
          <description>propofol 1mg/kg as a bolus intravenously followed by an infusion of 25-100 ug/kg/min
propofol: propofol 1mg/kg intravenously as a bolus followed by 25-100ug/kg/min</description>
        </group>
        <group group_id="P2">
          <title>Dexmedetomidine Infusion</title>
          <description>Subject will receive a bolus of0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug.
Dexmedetomidine infusion: bolus of 0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>surgery cancelled</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Propofol</title>
          <description>propofol 1mg/kg as a bolus intravenously followed by an infusion of 25-100 ug/kg/min
propofol: propofol 1mg/kg intravenously as a bolus followed by 25-100ug/kg/min</description>
        </group>
        <group group_id="B2">
          <title>Dexmedetomidine Infusion</title>
          <description>Subject will receive a bolus of0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug.
Dexmedetomidine infusion: bolus of 0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
            <count group_id="B2" value="37"/>
            <count group_id="B3" value="76"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40" lower_limit="40" upper_limit="60"/>
                    <measurement group_id="B2" value="52" lower_limit="42.8" upper_limit="61.2"/>
                    <measurement group_id="B3" value="46" lower_limit="40" upper_limit="61.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>total participants</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Adequate Sedation Via Bispectral Index Score (BIS)and University of Michigan Sedation Scale (UMSS)</title>
        <description>Bispectral Index Score measurement uses processed electroencephalogram signals to measure sedation depth of a scale from 0-100 (0=coma; 40-60=general anesthesia;60-90 sedated;100=awake) University of Michigan Sedation Scale (1-4) is an observational scale that quantifies sedation.1=normal response to verbal stimuli, 2=conscious sedation, responsive to tactile stimuli, 3= deeply sedated responsive to repeated or painful stimuli, 4=general anesthesia: not arousable.</description>
        <time_frame>Intraoperative up to 120 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>BIS Scores in Propofol Infusion Group</title>
            <description>propofol 1mg/kg as a bolus intravenously followed by an infusion of 25-100 ug/kg/min
propofol: propofol 1mg/kg intravenously as a bolus followed by 25-100ug/kg/min</description>
          </group>
          <group group_id="O2">
            <title>BIS Scores in Dexmedetomidine Infusion Group</title>
            <description>Subject will receive a bolus of 0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug.
Dexmedetomidine infusion: bolus of 0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug</description>
          </group>
          <group group_id="O3">
            <title>UMSS Scores in Propofol Infusion Group</title>
            <description>Propofol medication administered as described in BIS group/Propofol group</description>
          </group>
          <group group_id="O4">
            <title>UMSS in Dexmedetomidine Infusion Group</title>
            <description>subject received medication as described in BIS/dexmedetomidine</description>
          </group>
        </group_list>
        <measure>
          <title>Adequate Sedation Via Bispectral Index Score (BIS)and University of Michigan Sedation Scale (UMSS)</title>
          <description>Bispectral Index Score measurement uses processed electroencephalogram signals to measure sedation depth of a scale from 0-100 (0=coma; 40-60=general anesthesia;60-90 sedated;100=awake) University of Michigan Sedation Scale (1-4) is an observational scale that quantifies sedation.1=normal response to verbal stimuli, 2=conscious sedation, responsive to tactile stimuli, 3= deeply sedated responsive to repeated or painful stimuli, 4=general anesthesia: not arousable.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.8" lower_limit="77.5" upper_limit="92.1"/>
                    <measurement group_id="O2" value="88" lower_limit="78" upper_limit="94"/>
                    <measurement group_id="O3" value=".90" lower_limit=".47" upper_limit="1.33"/>
                    <measurement group_id="O4" value=".94" lower_limit=".43" upper_limit="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>Regression, Logistic</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>UMSS scores with subjects propofol vs. Dexmetomidine group</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.68</p_value>
            <method>Regression, Linear</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Achieve &quot;Street Fitness&quot;</title>
        <description>Subjects will be kept in the Post Anesthesia Care Unit (PACU) for a period of 2 hours. However it will be documented as to when, in the opinion of the PACU staff, the subject has met the criteria for discharge.</description>
        <time_frame>for 2 hours post-operatively in Post Anesthesia Care unit</time_frame>
        <population>Subjects meet criteria for discharge based upon the assessment from a professional independent of the study</population>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>propofol 1mg/kg as a bolus intravenously followed by an infusion of 25-100 ug/kg/min
propofol: propofol 1mg/kg intravenously as a bolus followed by 25-100ug/kg/min</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine Infusion</title>
            <description>Subject will receive a bolus of0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug.
Dexmedetomidine infusion: bolus of 0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Achieve &quot;Street Fitness&quot;</title>
          <description>Subjects will be kept in the Post Anesthesia Care Unit (PACU) for a period of 2 hours. However it will be documented as to when, in the opinion of the PACU staff, the subject has met the criteria for discharge.</description>
          <population>Subjects meet criteria for discharge based upon the assessment from a professional independent of the study</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="54" upper_limit="108"/>
                    <measurement group_id="O2" value="85" lower_limit="49.8" upper_limit="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intraoperative Hemodynamic Stability</title>
        <description>systolic and diastolic blood pressure was recorded at 5 minute intervals up to 120 min and were averaged per study arm</description>
        <time_frame>Intraoperative up to 120 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group -Mean Systolic Blood Pressure</title>
            <description>propofol 1mg/kg as a bolus intravenously followed by an infusion of 25-100 ug/kg/min
propofol: propofol 1mg/kg intravenously as a bolus followed by 25-100ug/kg/min</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine Group-mean Systolic Blood Pressure</title>
            <description>Subject will receive a bolus of0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug.
Dexmedetomidine infusion: bolus of 0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug</description>
          </group>
          <group group_id="O3">
            <title>Propofol Group- Mean Diastolic Blood Pressure</title>
            <description>propofol administered as described- blood pressure recorded at 5 min intervals during surgery</description>
          </group>
          <group group_id="O4">
            <title>Dexmedetomidine Group- Mean Diastolic Blood Pressure</title>
            <description>dexmedetomidine as already described and blood pressure monitored 5 min intervals,</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Hemodynamic Stability</title>
          <description>systolic and diastolic blood pressure was recorded at 5 minute intervals up to 120 min and were averaged per study arm</description>
          <units>mm/Hg</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124.9" lower_limit="108.7" upper_limit="141.1"/>
                    <measurement group_id="O2" value="114.6" lower_limit="100.1" upper_limit="129.1"/>
                    <measurement group_id="O3" value="73.6" lower_limit="61.1" upper_limit="86.1"/>
                    <measurement group_id="O4" value="66.2" lower_limit="55.4" upper_limit="77.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intraoperative Respiratory Stability</title>
        <description>respiratory rate data were recorded at 5 minutes intervals throughout the surgical procedure up to 120 mins for both groups and averaged per study arm</description>
        <time_frame>Intraoperative up to 120 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>subjects randomized to propofol group had their respiratory rate recorded at 5 minute intervals during the operative procedure.</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine Group</title>
            <description>subjects randomized to dexmedetomidine group had their respiratory rate recorded at 5 minute intervals during the operative procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Respiratory Stability</title>
          <description>respiratory rate data were recorded at 5 minutes intervals throughout the surgical procedure up to 120 mins for both groups and averaged per study arm</description>
          <units>breaths per minute</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="12" upper_limit="22"/>
                    <measurement group_id="O2" value="12" lower_limit="8" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intraoperative Heart Rate Stability</title>
        <description>Heart rate recorded at 5 minute intervals during surgery up to 120 min and averaged per study arm</description>
        <time_frame>Intraoperative up to 120 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Heart rate recorded at 5 minute intervals during procedure for subjects randomized to propofol</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine</title>
            <description>Heart rate recorded at 5 minute interval for subjects randomized to dexmedetomidine</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Heart Rate Stability</title>
          <description>Heart rate recorded at 5 minute intervals during surgery up to 120 min and averaged per study arm</description>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" lower_limit="58" upper_limit="84"/>
                    <measurement group_id="O2" value="64" lower_limit="49" upper_limit="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surgeon Satisfaction for Adequate Sedation</title>
        <description>1=very poor, 2=poor,3=fair, 4=good, 5=excellent</description>
        <time_frame>at 10 minutes into the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>surgeon satisfaction at 10 minutes in to the procedure for subjects randomized to propofol</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine Group</title>
            <description>surgeon satisfaction at 10 minutes into the procedure</description>
          </group>
        </group_list>
        <measure>
          <title>Surgeon Satisfaction for Adequate Sedation</title>
          <description>1=very poor, 2=poor,3=fair, 4=good, 5=excellent</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.62" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O2" value="4.97" lower_limit="3" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surgeon Satisfaction for Adequate Sedation at Completion of Procedure</title>
        <description>surgeon satisfaction graded on numerical scale 1=very poor. 2=poor, 3=fair 4=good, 5=excellent</description>
        <time_frame>immediately following the completion of the procedure up to one hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>patients receiving comparison drug propofol</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine Group</title>
            <description>patients receiving study drug dexmedetomidine</description>
          </group>
        </group_list>
        <measure>
          <title>Surgeon Satisfaction for Adequate Sedation at Completion of Procedure</title>
          <description>surgeon satisfaction graded on numerical scale 1=very poor. 2=poor, 3=fair 4=good, 5=excellent</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.77" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O2" value="4.89" lower_limit="3" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>1=very poor, 2=poor, 3=fair, 4=very good, 5=excellent</description>
        <time_frame>measured prior to discharge up to 2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol</title>
            <description>patient satisfaction prior to discharge on a 5 point scale1=very poor, 2=poor, 3=fair, 4= good , 5=excellent</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine Group</title>
            <description>patient satisfaction
1=very poor, 2=poor, 3=fair, 4= good, 5=excellent</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>1=very poor, 2=poor, 3=fair, 4=very good, 5=excellent</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.61" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O2" value="4.43" lower_limit="3" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Operative Hemodynamic Stability</title>
        <description>blood pressure documented at 30 minute intervals in PACU up to 120 min</description>
        <time_frame>2 hours in PACU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>systolic blood pressure at 30 min intervals in PACU</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine Group</title>
            <description>systolic blood pressure measured at 3 0 min. intervals in PACU</description>
          </group>
          <group group_id="O3">
            <title>Propofol</title>
            <description>diastolic blood pressure recorded every 30 min in PACU</description>
          </group>
          <group group_id="O4">
            <title>Dexmedetomidine</title>
            <description>diastolic pressure measured every 30 min in PACU</description>
          </group>
        </group_list>
        <measure>
          <title>Post Operative Hemodynamic Stability</title>
          <description>blood pressure documented at 30 minute intervals in PACU up to 120 min</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="39"/>
                <count group_id="O4" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124.9" lower_limit="108.7" upper_limit="141.1"/>
                    <measurement group_id="O2" value="114.6" lower_limit="100.1" upper_limit="129.1"/>
                    <measurement group_id="O3" value="73.6" lower_limit="61.1" upper_limit="86.1"/>
                    <measurement group_id="O4" value="66.2" lower_limit="55.4" upper_limit="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemodynamic Stability Post Operatively in PACU</title>
        <description>heart rate recorded at 30 min intervals in PACU up to 120 min</description>
        <time_frame>PACU to 2 hours post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>heart rate recorded in 30 min intervals in PACU ( 2 hours)</description>
          </group>
          <group group_id="O2">
            <title>Dexmedetomidine</title>
            <description>heart rate recorded at at 30 min intervals while in PACU (2 hours)</description>
          </group>
        </group_list>
        <measure>
          <title>Hemodynamic Stability Post Operatively in PACU</title>
          <description>heart rate recorded at 30 min intervals in PACU up to 120 min</description>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.1" lower_limit="72" upper_limit="77"/>
                    <measurement group_id="O2" value="72" lower_limit="71" upper_limit="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Heart rate, blood pressure, pulse oximetry are collected for all patients undergoing sedation or anesthesia for the entire time they are in the operating room which was between 1-2 hrs. Additionally heart rate, blood pressure, pulse oximetry were monitored for 2 hours in the Post Anesthesia Care Unit where patients are placed immediately following the procedure.</time_frame>
      <desc>Change in ECG, T wave inversion was noted on the cardiac monitor in the operating room, no intervention was required and the surgery continued without incident. A cardiology consult was called and the subject was admitted for observation. A myocardial perfusion test demonstrated a fixed deficit in the left ventricle, the Ejection fraction was 55% and serial Troponin levels were&lt;0.2, well below threshold for evidence of myocardial injury</desc>
      <group_list>
        <group group_id="E1">
          <title>Propofol</title>
          <description>propofol 1mg/kg as a bolus intravenously followed by an infusion of 25-100 ug/kg/min
propofol: propofol 1mg/kg intravenously as a bolus followed by 25-100ug/kg/min</description>
        </group>
        <group group_id="E2">
          <title>Dexmedetomidine Infusion</title>
          <description>Subject will receive a bolus of0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug.
Dexmedetomidine infusion: bolus of 0.5ug/kg intravenously over a period of 10-15 minutes, followed by an infusion of 0.2-0.7ug/kg/hr of drug</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>T wave inversion on EKG</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Termination of study due to difficulty recruiting subjects who fit the study criteria.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Anuradha Patel, MD</name_or_title>
      <organization>Rutgers New Jersey Medical School</organization>
      <phone>973 972-1886</phone>
      <email>patelan@njms.rutgers.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

